INTRODUCTIONMedication compounding gained national attention in 2012 after contaminated compounded medications produced in the New England Compounding Center caused an infectious outbreak that led to several fatalities. In addition, rising…

INTRODUCTIONPsoriasis is a chronic immune-mediated disease with predominant skin involvement. Multiple randomized studies of biologic agents have demonstrated the need for continual treatment.1-9 Open-label extensions of clinical trials conducted to…

INTRODUCTIONPsoriasis is a chronic, systemic, inflammatory disease that affects 1% to 4% of the population worldwide,1 including an estimated 7.4 million US adults.2,3 Many patients report that psoriasis has a…

INTRODUCTIONPsoriasis is a chronic inflammatory skin disease that affects as many as 7.4 million adults in the United States.1,2 It is characterized by disfiguring, scaling, erythematous plaques that can be…

INTRODUCTIONPsoriasis is a chronic, immune-mediated disease affecting almost 2% of the population.1-3 Topical therapy is a key component in the management of almost all psoriasis patients, considered first-line therapy for…

INTRODUCTIONPsoriasis is a chronic disease that has a substantial effect on quality of life (QoL), and the psychosocial disability suffered by psoriasis patients highlights the need for prompt, effective, and…

INTRODUCTIONOrally administered psoriasis therapies that can provide high levels of efficacy, safety, and tolerability remain an unmet need. Toreforant is an orally bioavailable, novel, and selective histamine H4 receptor (H4R)…

INTRODUCTIONPsoriasis is a chronic, immune-mediated inflammatory disease that affects >3% of adults aged ≥20 years in the United States.1,2 Primarily characterized by localized scaling and plaques that can cause itching…

INTRODUCTIONPharmaceutical companies spend billions of dollars yearly advertising medications. Spending on direct to consumer advertisements for psoriasis agents in particular has increased considerably over the last several year. Four of…

INTRODUCTIONThe incidence of mycologic diseases is rising, due to the increased use of communal recreational facilities, as well as the increased incidence of individuals who are immunocompromised.1 Tinea pedis, also…

INTRODUCTIONPoly-L-lactic acid (PLLA; Sculptra®, Galderma, Fort Worth, TX) injection is an effective treatment option for correction of bony and soft tissue facial deficiencies.1 PLLA, as synthetic polymer derivative from the…